Therapeutic and delivery methods of prostaglandin EP4 agonists

Details for Australian Patent Application No. 2012227306 (hide)

Owner Allergan, Inc.

Inventors Gil, Daniel W.; Old, David W.; Donello, John E.; Kedzie, Karen M.; Donde, Yariv; Burk, Robert M.; Gac, Todd S.; Im, Wha Bin; Holoboski, Mark

Agent Davies Collison Cave

Pub. Number AU-A-2012227306

Parent 2005299473

Filing date 25 September 2012

Wipo publication date 18 October 2012

International Classifications

C07C 405/00 Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/557 - Eicosanoids, e.g. leukotrienes

A61K 47/48 Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

11 October 2012 Complete Application Filed

18 October 2012 Application Open to Public Inspection

  Published as AU-A-2012227306

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012227307-Method of managing a life insurance policy with a related medical scheme

2012227305-Inflatable device for blocking chimney flues or other ducts